Chimerix, Inc., a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, announced that Kenneth I. Moch, its President and Chief Executive Officer, will present a company overview at the 12th Annual Needham Healthcare Conference on Wednesday, May 1, 2013 at 3:00 p.m. ET at the Westin New York Grand Central Hotel in New York City.
No comments:
Post a Comment